medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2005, Number 5

<< Back Next >>

Rev Mex Oftalmol 2005; 79 (5)

Intravitreal triamcinolone as contributor in the treatment of diffuse diabetic macular edema.

Velasco-Fuentes I, De la Fuente-Torres M

Language: Spanish
References: 11
Page: 258-262
PDF size: 43.03 Kb.


ABSTRACT

Diabetic macular edema is an important cause of visual loss. Photocoagulation in diffuse macular edema improves visual acuity in a reduced percentage of patients. Intravitreal triamcinolone has been reported useful in patients refractive to treatment.
Purpose: Evaluate evolution of eyes with diffuse diabetic macular edema without previous treatment after injection of intravitreal triamcinolone and photocoagulation .
Methods: 20 eyes of 10 patients with diabetic macular edema were enrolled in the study. Right eyes were assigned to the study group; left eyes were used as control. Macular photocoagulation was applied in both eyes; study group eyes received 4 mg intravitreal triamcinolone. Changes in visual acuity and intraocular pressure were registered at 30, 90, and 120 days.
Results: Mean visual acuity was 20/50 in both groups. At 6 months 40% in the study group improved visual acuity, 70% in the control group worsened. Intraocular pressure elevated in 20% of the study group.
Conclusion: There was no statistical difference in visual acuity between both groups; we suggest increasing sample size, and the need for reinjection.


REFERENCES

  1. 1. Klein R, Klein BE, Moss SE y col. The Wisconsin epidemiologic study of diabetic retinopathy XV: the long-term incidence of macular edema. Ophthalmology 1995; 102:7-16.

  2. 2. Kaiser PK, Riemann CD. Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 2001; 131:44-49.

  3. 3. Hideharu F, Hidetoshi Y. Increased level of vascular endotelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 2002; 133:70-77.

  4. 4. Yamamoto T, Akabame N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 2001; 132: 369.77.

  5. 5. Early Treatment Diabetic Retinopathy Study Research group. Photocoagulation for diabetic macular edema. Early treatment Diabetic Retinopathy Study Report number 1. Arch Ophthalmol 1985; 103:1796-1806.

  6. 6. Early Treatment Diabetic retinopathy study research group. Ophthalmology 1991; 98:766-785. Early photocoagulation for diabetic retinopathy. ETDRS report number 9

  7. 7. Jost B, Jonas MD, Jochen K, Hayler MD y col. Intravitreal Injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001; 131:468-471.

  8. 8. Jost B, Jonas MD, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132:425-427.

  9. 9. Tano Y, Chandler D, Machemer R. Treatment of Intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980; 90: 810-816.

  10. 10. Jost B, Jonas MD, Robert F. Intravitreal injection of triamcinolone acetonide as treatment of diffuse diabetic macular edema. Klin Monatsbl Augenheilkd 2002; 219(6):429-32.

  11. 11. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109(5): 920-7.




2020     |     www.medigraphic.com